A Multicenter Randomized Phase II Trial in NSCLC Stage IV et IIIB in Elderly Dependent Patients With Evaluation of the Sequence Gemcitabine First Line Followed by Erlotinib When Progression Versus Erlotinib First Line Followed by Gemcitabine When Progression.
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2013
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Jul 2012 Results published in the Lung Cancer.
- 09 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.